These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2566953)

  • 1. Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits.
    Beal MF; Mazurek MF; Ellison DW; Kowall NW; Solomon PR; Pendlebury WW
    Neuroscience; 1989; 29(2):339-46. PubMed ID: 2566953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem.
    Kowall NW; Pendlebury WW; Kessler JB; Perl DP; Beal MF
    Neuroscience; 1989; 29(2):329-37. PubMed ID: 2725861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of aluminum Alzheimer's disease, and neurofibrillary tangles.
    Perl DP; Good PF
    J Neural Transm Suppl; 1987; 24():205-11. PubMed ID: 3316495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum neurotoxicity--potential role in the pathogenesis of neurofibrillary tangle formation.
    Perl DP; Pendlebury WW
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):441-5. PubMed ID: 3791060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of neurotransmitter abnormalities in Alzheimer's disease.
    Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity.
    Scholtz CL; Swash M; Gray A; Kogeorgos J; Marsh F
    Clin Neuropathol; 1987; 6(3):93-7. PubMed ID: 3608291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease.
    Bondareff W; Mountjoy CQ; Roth M; Hauser DL
    Neurobiol Aging; 1989; 10(6):709-15. PubMed ID: 2628782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rabbit retina: a long-term model system for aluminum-induced neurofibrillary degeneration.
    Fry KR; Edwards DM; Shaw KA; Watt CB
    Neurosci Lett; 1991 Apr; 124(2):216-20. PubMed ID: 2067721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of immunocytochemical, neurochemical, and behavioral studies in aluminum-induced neurofilamentous degeneration.
    Pendlebury WW; Beal MF; Kowall NW; Solomon PR
    J Neural Transm Suppl; 1987; 24():213-7. PubMed ID: 3479524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum and Alzheimer's disease.
    McLachlan DR
    Neurobiol Aging; 1986; 7(6):525-32. PubMed ID: 3550508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum-induced decreases in choline acetyltransferase, tyrosine hydroxylase, and glutamate decarboxylase in selected regions of rabbit brain.
    Hofstetter JR; Vincent I; Bugiani O; Ghetti B; Richter JA
    Neurochem Pathol; 1987 Jun; 6(3):177-93. PubMed ID: 2888068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathologic and neurochemical correlates of psychosis in primary dementia.
    Zubenko GS; Moossy J; Martinez AJ; Rao G; Claassen D; Rosen J; Kopp U
    Arch Neurol; 1991 Jun; 48(6):619-24. PubMed ID: 1710105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum chloride induced neurofibrillary changes in the developing rabbit a chronic animal model.
    Wisniewski HM; Sturman JA; Shek JW
    Ann Neurol; 1980 Nov; 8(5):479-90. PubMed ID: 7192069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
    Savory J; Huang Y; Wills MR; Herman MM
    Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity uptake of GABA and glycine by rabbits with aluminum-induced neurofibrillary changes.
    Sturman JA; Wisniewski HM; Shek JW
    Neurochem Res; 1983 Sep; 8(9):1097-109. PubMed ID: 6633788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
    Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum-induced neurofibrillary changes in axons and dendrites.
    Wisniewski HM; Shek JW; Gruca S; Sturman JA
    Acta Neuropathol; 1984; 63(3):190-7. PubMed ID: 6464675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alzheimer's type dementia: recent data].
    Lamour Y; Davous P
    Presse Med; 1983 May; 12(22):1415-20. PubMed ID: 6134279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning deficit in immature rabbits with aluminum-induced neurofibrillary changes.
    Rabe A; Lee MH; Shek J; Wisniewski HM
    Exp Neurol; 1982 May; 76(2):441-6. PubMed ID: 6896495
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.
    Crapper DR; Krishnan SS; Dalton AJ
    Science; 1973 May; 180(4085):511-3. PubMed ID: 4735595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.